Do you want to skip to content? Skip to content
Convatec Group Contact Us България България Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Österreich Österreich Schweiz (Deutsch) Schweiz (Deutsch) Deutschland Deutschland Ελλάδα Ελλάδα United Kingdom United Kingdom Ireland Ireland España España Eesti Eesti Suomi Suomi Suisse (Français) Suisse (Français) France France Hrvatska Hrvatska Magyarország Magyarország Ísland Ísland Italia Italia Lietuva Lietuva Latvija Latvija Северна Македонија Северна Македонија Malta Malta Norge Norge België België Nederland Nederland Polska Polska Portugal Portugal România România Slovensko Slovensko Slovenija Slovenija Srbija Srbija Sverige Sverige Türkiye Türkiye Україна Україна Brasil Brasil United States (English) United States (English) Estados Unidos (Español) Estados Unidos (Español) Argentina Argentina Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Ecuador Ecuador México México Perú Perú Belize Belize Guyana Guyana Jamaica Jamaica Venezuela Venezuela Costa Rica Costa Rica Curaçao Curaçao República Dominicana República Dominicana Guatemala Guatemala Honduras Honduras Nicaragua Nicaragua Panamá Panamá Puerto Rico Puerto Rico Suriname Suriname El Salvador El Salvador الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين مصر مصر ישראל ישראל ایران ایران الأردن الأردن عُمان عُمان قطر قطر پاکستان پاکستان لبنان لبنان الكويت الكويت المملكة العربية السعودية المملكة العربية السعودية Suid-Afrika Suid-Afrika العراق العراق New Zealand New Zealand 日本 日本 Australia Australia India India Malaysia Malaysia Singapore Singapore 대한민국 대한민국 中国大陆 中国大陆 中国台湾 中国台湾 ไทย ไทย Indonesia Indonesia Việt Nam Việt Nam Philippines Philippines Hong Kong SAR China (English) Hong Kong SAR China (English) 中国香港特别行政区 (中文(简体,中国香港特别行政区)) 中国香港特别行政区 (中文(简体,中国香港特别行政区))
False /oidc-signin/en-gb/ Convatec Group Contact Us България България Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Österreich Österreich Schweiz (Deutsch) Schweiz (Deutsch) Deutschland Deutschland Ελλάδα Ελλάδα United Kingdom United Kingdom Ireland Ireland España España Eesti Eesti Suomi Suomi Suisse (Français) Suisse (Français) France France Hrvatska Hrvatska Magyarország Magyarország Ísland Ísland Italia Italia Lietuva Lietuva Latvija Latvija Северна Македонија Северна Македонија Malta Malta Norge Norge België België Nederland Nederland Polska Polska Portugal Portugal România România Slovensko Slovensko Slovenija Slovenija Srbija Srbija Sverige Sverige Türkiye Türkiye Україна Україна Brasil Brasil United States (English) United States (English) Estados Unidos (Español) Estados Unidos (Español) Argentina Argentina Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Ecuador Ecuador México México Perú Perú Belize Belize Guyana Guyana Jamaica Jamaica Venezuela Venezuela Costa Rica Costa Rica Curaçao Curaçao República Dominicana República Dominicana Guatemala Guatemala Honduras Honduras Nicaragua Nicaragua Panamá Panamá Puerto Rico Puerto Rico Suriname Suriname El Salvador El Salvador الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين مصر مصر ישראל ישראל ایران ایران الأردن الأردن عُمان عُمان قطر قطر پاکستان پاکستان لبنان لبنان الكويت الكويت المملكة العربية السعودية المملكة العربية السعودية Suid-Afrika Suid-Afrika العراق العراق New Zealand New Zealand 日本 日本 Australia Australia India India Malaysia Malaysia Singapore Singapore 대한민국 대한민국 中国大陆 中国大陆 中国台湾 中国台湾 ไทย ไทย Indonesia Indonesia Việt Nam Việt Nam Philippines Philippines Hong Kong SAR China (English) Hong Kong SAR China (English) 中国香港特别行政区 (中文(简体,中国香港特别行政区)) 中国香港特别行政区 (中文(简体,中国香港特别行政区))

Aquacel® Ag dressings have been replaced by Aquacel® Ag+ dressings

Remember + when you prescribe

a blue and white box ;

We have simplified our anti-infective range and discontinued the old Aquacel® Ag, Aquacel® Ag Extra and Aquacel® Ag Ribbon dressings. This means they are no longer on Drug Tariff or available on prescription. 

These have been replaced with Aquacel® Ag+ Dressings, our award winning anti-infective dressing:
ALL the benefits of old Aquacel® Ag
The addition of MORE THAN SILVER™ Technology, specifically developed to win the battle against biofilm
Even better outcomes for your patients at no extra cost

Remember to update your codes, and include the + or write the new PIP codes when prescribing or your patients may experience delays. 

Any prescriptions for Aquacel® Ag dressings should be returned to the surgery for amending and not be dispensed.

table ;

How it Works

Surfactants help to dissolve and remove contamination from surfaces by lowering the surface tension and can be found in products such as skin wipes. MORE THAN SILVER™ technology incorporates BEC (Benzethonium chloride).

BEC reduces the surface tension within a biofilm to enhance the ability of EDTA to remove metal ions in biofilm. BEC and EDTA synergistically work together to disrupt biofilm structures aiding the absorption and removal of the EPS and microorganisms by the dressing1-5.

Chelating agents are compounds that strongly attract and bind certain metal ions, boosting the action of surfactants. MORE THAN SILVER™ technology incorporates EDTA (ethylenediaminetetraacetic acid disodium salt).

EDTA helps disrupt biofilm by removing metal ions that hold the EPS matrix together to expose microorganisms to the antimicrobial effects of the ionic silver1-4.

A broad-spectrum antimicrobial.
 
Silver is a safe, broad-spectrum antimicrobial that is only effective in its ionic form. Attracted to sites on bacterial cell walls, it accumulates and then enters the cell, where it damages the DNA, denatures proteins and enzymes, and interferes with protein synthesis.
 
The cell wall becomes porous and the contents leak out, leading to cell death 6-7.

The AQUACEL® Ag+ Extra™ difference

Distrupt and destroy Biofilm with AQUACEL ™ Ag+ Extra™ ;

Distrupt and destroy Biofilm with AQUACEL ™ Ag+ Extra™

Advancing healing in stalled, deteriorating chronic wounds.

Multicentre clinical study monitoring the use of AQUACEL® Ag+ dressings on 111 patients with non-healing wounds.9
timeline ;

Objective

To demonstrate the ability of AQUACEL® Ag+ dressings to promote healing in chronic wounds that were stalled or deteriorating at baseline.

Results indicated that:

  • 78% improved
  • 13% healed (average evaluation period of 3.9 weeks.
  • 83% progressed in key healing parameters

For more information about the discontinuation, support in updating your codes or to Learn more about how Aquacel® Ag+ Extra can help you disrupt and destroy biofilm, please complete your details below.

Are you currently in contact with a Convatec representative?

How we use information: Treating your personal data with care is important to us. Please read our privacy policy where you can find detailed information on how we protect and use personal date.

How we use information: Treating your personal data with care is important to us. Please read our privacy policy where you can find detailed information on how we protect and use personal date.

Consent to Data Processing
Consent to Marketing

You can opt out of receiving marketing messages anytime by contacting us by telephone at 01244 284 882 (UK) or by email at uk.customerservice@convatec.com. You may also click on the ‘Unsubscribe’ link in the footer of the emails you will receive.

You can opt out of receiving marketing messages anytime by contacting us by telephone at 01244 284 882 (UK) or by email at uk.customerservice@convatec.com. You may also click on the ‘Unsubscribe’ link in the footer of the emails you will receive.

References

1. Said J, Walker M, Parsons D, Stapleton P, Beezer AE, Gaisford S. An in vitro test of the efficacy of an anti-biofilm wound dressing. Int J Pharmaceutics. 2014; 474: 177–181. DOI: 10.1016/jijpharm.2014.08.034.

2. Composition comprising antimicrobial metal ions and a quaternary cationic surfactant WO12136968 Parsons World patent application 11th October 2012 .

3. Banin E., Brady K.M. & Greenberg E.P. (2006). Chelator Induced Dispersal and Killing of Pseudomonas aeruginosa Cells in Biofilm. Appl. Environ. Microbiol. 72. 2064 2069.

4. Chen X, Stewart PS, 2000. Biofilm removal caused by chemical treatments. Wat. Res.,34: 4229 4233.

5. Seth AK, Zhong A, Nguyen KT, Hong SJ, Leung KP, Galiano RD, Mustoe TA. Impact of a novel, antimicrobial dressing on in vivo, Pseudomonas aeruginosa wound biofilm: quantitative comparative analysis using a rabbit ear model. Wound Repair Regen. 2014; 22: 712–719. DOI: 10.1111/wrr.12232.

6. Hobot JA, Walker M, Newman GN, Bowler PG, 2008. Effect of Hydrofiber® wound dressings on bacterial ultrastructure. J Electr Micro; 57: 67-75.

7. T. J. Beveridge, W. S. Fyfe. Metal fixation by bacterial cell walls. Canadian Journal of Earth Sciences, 1985, 22(12): 1893-1898, https://doi.org/10.1139/e85-204.

8. Malone M et al. 2017. The prevalence of biofilm in chronic wounds: a systematic review and meta-analysis of published data. JWC; 20-25.

9. Metcalf DG, Parsons D, Bowler PG. Clinical safety and effectiveness evaluation of a new antimicrobial wound dressing designed to manage exudate, infection and biofilm. Int Wound J 2017; 14: 203-213

You are leaving convatec.com

This Internet site may provide links or references to other sites but Convatec have no responsibility for the content of such other sites and shall not be liable for any damages or injury arising from that content. Any links to other sites are provided as merely a convenience to the users of this Internet site.

Do you wish to continue?